Real World Evidence asthma and COPD inhaled treatment therapy in Spain release_ashy6hjlovaipnbwcbaedgockm

by Xavier Muñoz, Jordi Giner, Antoni Sicras, Daniele Lo Re

Published in Respiratory care by Daedalus Enterprises.

2024   Volume 69, Issue 12, respcare.11643

Abstract

This study aimed to describe the use of pressurized metered-dose inhalers (pMDIs) and dry powder inhalers (DPIs) in Spanish subjects in terms of sociodemographic, clinical, and functional characteristics in subjects with asthma or COPD on maintenance treatment with inhaled therapy. This was a retrospective, descriptive, national, multi-center, and observational study using a database with 1.8 million patients from hospitals and primary care centers as a secondary information source. The sample included 24,102 subjects with asthma on maintenance therapy (26.0% with pMDI, 55% with DPI, and 19.0% with a combination of DPI + pMDI inhalers) and 12,858 subjects with COPD on maintenance therapy (26% with pMDI; 39% with DPI; and 35% with a combination of pMDI + DPI inhalers, mostly extemporary triple therapy). In proportion, subjects ≥ 75 y old used more pMDI than DPI, while younger subjects (40-64 y old) used more DPI. An inhalation chamber was prescribed in 51.0% of subjects with asthma and 47.2% of subjects with COPD treated with pMDI. The use of an inhalation chamber increases with the degree of air-flow limitation by disease and age. In subjects with comorbidities, pMDI inhaler use increased in those ≥ 75 y old for subjects with asthma and subjects with COPD. Switching from pMDI to DPI and vice versa was relatively common: 25% of subjects with asthma and 21.6% of subjects with COPD treated with pMDI had switched from DPI in the previous year. On the contrary, 14.1% and 11.4% of subjects with asthma and subjects with COPD, respectively, treated with DPI had switched from pMDI the last year. The use of pMDI or DPI can vary according to age, both in asthma and COPD. Switching from pMDI to DPI and vice versa is relatively common. Despite the availability of dual- and triple-therapy inhalers on the market, a considerable number of subjects were treated with multiple devices.
In text/plain format

Archived Files and Locations

application/pdf   1.4 MB
file_6ufcxgtawbavhgsdwdreaa6pvq
rc.rcjournal.com (publisher)
web.archive.org (webarchive)
Read Archived PDF
Preserved and Accessible
Type  article-journal
Stage   published
Date   2024-06-21
Language   en ?
Container Metadata
Not in DOAJ
In Keepers Registry
ISSN-L:  0020-1324
Work Entity
access all versions, variants, and formats of this works (eg, pre-prints)
Catalog Record
Revision: 55c0d2c9-2523-42b7-9904-80fe36e754bc
API URL: JSON